Browse By Region
Browse By Category
Recent News
By Category: Biotechnology
Harris Corp. awarded $9 million Army contract to boost biodefense
The U.S. Army recently signed a $9 million deal with Harris Corp. to bolster the army’s biological defense capabilities; Harris will provide the Army’s Joint Biological Point Detection System (JBPDS) with its advanced Falcon II AN/PRC-150 high-frequency radio system; the radio system is capable of detecting and identifying biological warfare agents and will automatically send Read More »
- February 25, 2011
- | Filed under North America, Biotechnology, and Countermeasures
Presidential Commission on Bioethics Releases Synthetic Biology Report
WASHINGTON—Today, the Presidential Commission on Bioethics released a new report calling for enhanced federal oversight of synthetic biology. The report is the result of over six months of discussions and deliberation, including three public meetings, and contains 18 recommendations stressing the need for enhanced government transparency, high-level coordination, periodic risk assessments, ethics education for scientists Read More »
- December 16, 2010
- | Filed under North America, Biotechnology, Policy & Initiatives, and Research
PharmaJet, AMRIID cooperating on needle-free smallpox vaccine
PharmaJet, Inc., and the U.S. Army Medical Research Institute of Infectious Diseases have signed a cooperative research and development agreement to combine PharmaJet’s needle-free jet injection delivery system and USAMRIID’s candidate gene-based smallpox
- December 8, 2010
- | Filed under Biotechnology
A flu vaccine that lasts
(NIH/National Institute of Allergy and Infectious Diseases) The costly, time-consuming process of making, distributing and administering millions of seasonal flu vaccines would become obsolete if researchers could design a vaccine that confers decades-long protection from any flu virus strain. Making such a universal influenza vaccine is feasible but licensing it may require innovation on several Read More »
- December 6, 2010
- | Filed under North America, Biotechnology, and Public Health